Search Results - Kevin M. Watt

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling by Venkata K. Yellepeddi, Kaustubh Parashar, Spencer M. Dean, Kevin M. Watt, Jonathan E. Constance, Olga J. Baker

Connect to this object online.

Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure by Rachel E. Hudson, Torri D. Metz, Robert M. Ward, Autumn M. McKnite, Elena Y. Enioutina, Catherine M. Sherwin, Kevin M. Watt, Kathleen M. Job

Connect to this object online.

Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling by J. Porter Hunt, Samuel Dubinsky, Autumn M. McKnite, Kit Wun Kathy Cheung, Bianca D. vanGroen, Kathleen M. Giacomini, Saskia N. deWildt, Andrea N. Edginton, Kevin M. Watt

Connect to this object online.

Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity by Jacqueline G. Gerhart, Fernando O. Carreño, Jennifer L. Ford, Andrea N. Edginton, Eliana M. Perrin, Kevin M. Watt, William J. Muller, Andrew M. Atz, Amira Al‐Uzri, Paula Delmore, Daniel Gonzalez, Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee

Connect to this object online.

Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants by Jacqueline G. Gerhart, Kevin M. Watt, Andrea Edginton, Kelly C. Wade, Sara N. Salerno, Daniel K. Benjamin Jr, P. Brian Smith, Christoph P. Hornik, Michael Cohen‐Wolkowiez, Shahnaz Duara, Ashley Ross, Karen Shattuck, Dan L. Stewart, Natalie Neu, Daniel Gonzalez, the Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee

Connect to this object online.